Post-approval studies (Phase 4)UnknownNCT04501900What this trial is testingThe 3 Years vs 1 Year DAPT After XINSORB BRS ImplantationWho this might be right forCardiovascular Diseases Shanghai Zhongshan Hospital 2,106
Post-approval studies (Phase 4)Looking for participantsNCT07076082What this trial is testingVascular Trial Associated Registry PilotWho this might be right forPeripheral Arterial Disease Corewell Health West 350
Not applicableStudy completedNCT03023020What this trial is testingManagement of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT RegimenWho this might be right forHigh Bleeding RiskCoronary Artery DiseasePCI ECRI bv 4,579
Not applicableStudy completedNCT06089304What this trial is testingPatient Centered Machine Learning Model for Bleeding and Ischemic RiskWho this might be right forCoronary Artery DiseasePercutaneous Coronary Intervention Abbott Medical Devices 19,000
Post-approval studies (Phase 4)Study completedNCT02939872What this trial is testingOptimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic EventsWho this might be right forPercutaneous Transluminal Coronary AngioplastyCoronary Disease Seung-Jung Park 238
Not applicableStudy completedNCT03310801What this trial is testingLAAO With DAPT Versus Antithrombotic TherapyWho this might be right forAtrial FibrillationCoronary Artery Disease Korea University Anam Hospital 480
Post-approval studies (Phase 4)Study completedNCT01069003What this trial is testingEDUCATE: The MEDTRONIC Endeavor Drug Eluting Stenting: Understanding Care, Antiplatelet Agents and Thrombotic EventsWho this might be right forCoronary Artery Disease Medtronic Vascular 2,272
Not applicableLooking for participantsNCT06535568What this trial is testingSingle vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)Who this might be right forCoronary DiseaseHeart DiseasesCardiovascular Diseases+22 more Fondazione Ricerca e Innovazione Cardiovascolare ETS 576
Not applicableStudy completedNCT03355742What this trial is testingXIENCE 28 Global StudyWho this might be right forBleeding DisorderStroke, IschemicStroke Hemorrhagic+6 more Abbott Medical Devices 963
Post-approval studies (Phase 4)UnknownNCT04090281What this trial is testingImplementing Precision Medicine Approaches to Guide Anti-platelet SelectionWho this might be right forAcute Coronary Syndrome (ACS)STEMI - ST Elevation Myocardial Infarction (MI)NSTEMI - Non-ST Segment Elevation MI+1 more University of Southern California 200
Post-approval studies (Phase 4)Study completedNCT01459627What this trial is testingRandomized, Open Label Trial of 6 Months Versus 12 Months DAPT After Drug-Eluting Stent in STEMIWho this might be right forMyocardial InfarctionCardiovascular Disease Maasstad Hospital 1,100
Not applicableStudy completedNCT02516267What this trial is testingEvaluation of Platelet Aggregability in the Release of CABG in Patients With ACS With DAPT.Who this might be right forBleeding University of Sao Paulo General Hospital 190
Post-approval studies (Phase 4)Active Not RecruitingNCT05631769What this trial is testingHOST - DAPT Duration According the Bleeding RiskWho this might be right forCoronary Artery DiseaseAcute Myocardial InfarctionStable Angina Seoul National University Hospital 4,900
Post-approval studies (Phase 4)Not Yet RecruitingNCT06763744What this trial is testingGenotype-Guided Abbreviated DAPT Versus Un-Guided De-escalation Therapy in Patients With ACS and HBRWho this might be right forAcute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)High Bleeding Risk Samsung Medical Center 3,000
Post-approval studies (Phase 4)Looking for participantsNCT05491200What this trial is testingComparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI PatientsWho this might be right forST Elevated Myocardial InfarctionDual Antiplatelet Therapy Research Maatschap Cardiologen Rotterdam Zuid 1,656
Post-approval studies (Phase 4)Study completedNCT07622056What this trial is testingPharmacodynamic and Short-term Effects of Half-dose Ticagrelor With or Without Aspirin vs DAPT From Day of PCI in CCSWho this might be right forCoronary Heart Disease Kaohsiung Veterans General Hospital. 54
Post-approval studies (Phase 4)Study completedNCT04006288What this trial is testingSwitching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery DiseaseWho this might be right forCoronary Artery Disease University of Florida 90
Not applicableLooking for participantsNCT05305482What this trial is testingDCS Versus DES for One-month DAPT in Patients With ACS: ONE-PASS TrialWho this might be right forAcute Coronary Syndrome Yonsei University 3,520
Post-approval studies (Phase 4)Study completedNCT04624854What this trial is testingDual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)Who this might be right forCoronary Artery DiseaseMyocardial IschemiaAcute Coronary Syndrome+7 more Harbin Medical University 8,250
Post-approval studies (Phase 4)UnknownNCT04116931What this trial is testingOPTImal Management of Antithrombotic Agents: OPTIMA-5Who this might be right forAcute Coronary Syndrome (ACS) The First Affiliated Hospital with Nanjing Medical University 80